Business

Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference

RADNOR, Pa., May 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that management will be participating in the Jefferies 2026 Global Healthcare Conference being held in New York on June 2-4, 2026. Jefferies Global Healthcare Co

articleMineralys Therapeutics, Inc.May 27, 20261/company/mineralys-therapeutics-inc-common-stock/news/mineralys-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference
Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference

About this update from Mineralys Therapeutics, Inc.

[{"type":"image","alt":"Mineralys Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Mineralys Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/7d27eb215a09ca1c260f3840d5c29c6c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oMsxZW8ttKTHAHjG2pEt6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMQ--/https://media.zenfs.com/en/globenewswire.com/7d27eb215a09ca1c260f3840d5c29c6c","width":300,"height":79},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/oMsxZW8ttKTHAHjG2pEt6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMQ--/https://media.zenfs.com/en/globenewswire.com/7d27eb215a09ca1c260f3840d5c29c6c","width":300,"height":79}},"lazy":false},{"type":"text","content":"RADNOR, Pa., May 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that management will be participating in the Jefferies 2026 Global Healthcare Conference being held in New York on June 2-4, 2026.","length":469,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"2","val":[{"type":"text","content":"Jefferies Global Healthcare Conference","length":38,"tagName":"p"}]}]},{"val":[{"style":"max-width:12%;width:12%;min-width:12%;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"max-width:88%;width:88%;min-width:88%;","val":[{"type":"text","content":"Wednesday, June 3, 2026","length":23,"tagName":"p","attribs":{}}]}]},{"val":[{"val":[{"type":"text","content":"Time:","length":5,"tagName":"p"}]},{"val":[{"type":"text","content":"7:35am EDT","length":10,"tagName":"p"}]}]},{"val":[{"val":[{"type":"text","content":"Format","length":6,"tagName":"p"}]},{"val":[{"type":"text","content":"Corporate Presentation","length":22,"tagName":"p"}]}]},{"val":[{"colspan":"2","val":[{"type":"text","content":"Webcast Link","length":12,"tagName":"p"}]}]}],"length":121},{"type":"text","content":"A live webcast of this presentation can also be accessed on the “News & Events” page in the Investor Relations section of the Mineralys Therapeutics website.","length":161,"tagName":...

More updates from Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc.biopharmaceutical companyGlobal Healthcare ConferenceMineralys Therapeuticschronic kidney diseaseobstructive sleep apneaJefferiesMineralys